Navigation Links
Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award
Date:1/14/2009

RIVER EDGE, N.J., Jan. 14 /PRNewswire-FirstCall/ -- Nephros, Inc. (Amex: NEP), is pleased to announce that it has received the prestigious 2009 Frost & Sullivan Medical Device Patient Care Company of the Year Award, for its rapid growth, progressive technology, and strategic product development.

Nephros was recognized for its ability to develop products that meet market demands. Nephros's breakthrough hemodiafiltration technology has resulted in rapid revenue growth as well as a new therapy for end-stage renal disease (ESRD). Its OLpur(TM) H2H(TM) Module and MD 220 filter received approval under an investigational device exemption (IDE) from the FDA in January 2007. By October, clinical trials were initiated at the Columbia University Dialysis Center in New York. In June 2008, Nephros completed a pivotal trial for its hemodiafiltration products and submitted a 510(k) application in November.

With the hemodialyzer market in the U.S. estimated at nearly $214 million in 2007, Nephros is positioned to generate returns in a maturing industry by offering a unique product supported by numerous scientific studies and clinical trials. While the therapy is pending approval in the U.S., it has already generated revenues in Europe, showing steady growth. Finally, through the leveraging of a platform modality and corporate restructuring, Nephros has taken steps to expand its user base and revenue growth.

Nephros was also recognized by Frost & Sullivan for finding applications of its core technology in other markets. While the company is actively pursuing approval for its online hemodiafiltration therapy, the technology has also found two immediate applications in water purification. With multiple reported outbreaks and deaths due to Legionnaire's disease this past year in institutional facili
'/>"/>

SOURCE Nephros, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
4. Dalcons Healthcare Communications Software Receives Internet Telephony Magazine Product of the Year Award
5. Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
6. WellPoint Receives Seven eHealthcare Leadership Awards
7. Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
8. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
9. Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO
10. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
11. AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 Problem Gambling Awareness Month ... join individuals and organizations across the nation in this ... health care professionals, policymakers, and others about problem gambling ... Compulsive Gambling (FCCG) and FCCG partner organizations are calling ... patients for a gambling problem, to make treatment readily ...
(Date:3/4/2015)... Miami, FL (PRWEB) March 04, 2015 ... diet, is showing promise in terms of extending life. ... have shown that this new dieting routine can help ... through antioxidant production clearly has long term benefits, many ... side-effects, thus a quicker substitute is necessary. As an ...
(Date:3/4/2015)... Los Angeles (PRWEB) March 04, 2015 ... patented Cunermuspir complex, the world’s first biocompatible copper chelate, ... MitoSynergy will offer guests the chance to gain insight ... learn about how the Cunermuspir complex can support their ... chair. , Cunermuspir, which is the core ingredient of ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... draw milk from the breast of a lactating mother through ... use for feeding the baby. Breast pumps are used when ... birth, or the mother being away from a child for ... others. Breast pumps are also used to stimulate lactation and ...
(Date:3/4/2015)... 04, 2015 Brassica Protection Products LLC, ... the rebrand of its SGS™ brand of glucoraphanin to ... percent glucoraphanin, which is the most concentrated source of ... initiative includes a new truebroc logo and refreshed website ... and brand name. , “We are thrilled to ...
Breaking Medicine News(10 mins):Health News:Problem Gambling - A Public Health Issue; March Is Problem Gambling Awareness Month 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3Health News:MitoSynergy Invites Expo West Attendees to Sit Back, Relax and Take Time for Their Health 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Increase in the Number of Nursing Mothers in the Workplace Spurs the Breast Pumps Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Brassica Protection Products Rebrands its SGS™ Brand of Glucoraphanin to truebroc™ 2
... Corporation,(Nasdaq: PODD ), the leader in patch pump ... appointment of Sally W.,Crawford to its board of directors. ... operating officer of Healthsource Inc., a managed care,organization. She ... firm in life sciences, on Insulet,s board of directors., ...
... lost to HIV/AIDS in South Africa from 2000 and ... program was not implemented, assert researchers from the Harvard ... online by the Journal of Acquired Immune Deficiency ... estimated 35,000 babies were born with HIV during that ...
... Sechrist Industries, Inc.,announced that it has been ... Partners, L.P., the group purchasing unit of ... 2008 through September 30, 2010, allows,Sechrist to ... hospitals,and 53,000 additional healthcare sites., (Logo: ...
... work with federal and state health agencies,to increase ... themselves on MRSA and C. diff prevention, ... Authority supports "International Infection Prevention,Week," October 19-25, 2008 ... and the public from healthcare-associated infections., The ...
... Members Report Some Payers Scaling Back Chronic Disease,Initiatives, ... Continuum,Alliance, responding to reports that many Americans are ... called for renewed vigilance,in the fight against chronic ... some forms of belt-tightening make sense in tough ...
... Psychemedics,Corporation (Nasdaq: PMD ) today announced that Raymond ... Ray will be responsible for all internal and ... and planning,activities necessary for the company,s continued growth. Ray ... 2005, Ray has served as Director of International Finance ...
Cached Medicine News:Health News:Sally W. Crawford Joins Insulet's Board of Directors 2Health News:Sally W. Crawford Joins Insulet's Board of Directors 3Health News:Sally W. Crawford Joins Insulet's Board of Directors 4Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 2Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 3Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 4Health News:Sechrist Industries, Inc. Awarded Premier Sole-Source Contract for Hyperbaric Oxygen Chambers 2Health News:Patient Safety Authority Supports 'International Infection Prevention Week' 2Health News:Patient Safety Authority Supports 'International Infection Prevention Week' 3Health News:Nation's Economic Downturn Threatens Continuity of Care for Chronic Conditions 2Health News:Raymond J. Ruddy Joins Psychemedics Corporation As Top Financial Officer 2
(Date:3/4/2015)... March 3, 2015, order from the Federal Drug Administration (FDA) ... to clarify the drugs, intended use and warn about a ... protect the public from injury from these products, according to ... Conroy . The order says that the drug ... taken by millions of U.S. men – are approved only ...
(Date:3/4/2015)... , March 4, 2015 XBiotech ... pilot study in patients with moderate to severe ... The open-label Phase II trial evaluated the potential ... antibody that targets interleukin-1 alpha (IL-1a). IL-1a is ... cells present in skin lesions. The Company claims ...
(Date:3/4/2015)... Minn. , March 4, 2015   Mayo ... an agreement to develop the next generation of wearable ... "We are hoping that this technology will be game-changer. ... and diabetes," says James Levine, M.D., Ph.D. , ... "They are accurate, inexpensive, and can be integrated into ...
Breaking Medicine Technology:Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 2Mayo Clinic and Gentag, Inc. Announce Agreement To Develop Wireless Sensors for Treatment of Obesity and Diabetes 3
... Anti-Viral Applications of Novel Targeted Agents Under ... Technology Platform -, - Anti-Viral Potential of ... at American Association of Immunologists Annual Meeting -, ... PPHM ), a clinical stage biopharmaceutical,company developing monoclonal antibodies ...
... Cardinal Health, a,global provider of products and ... care, today announced that it will now manufacture,compound ... trials., The company,s new services for the ... of Nuclear Medicine,s (SNM) 55th Annual Meeting,taking place ...
Cached Medicine Technology:Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 2Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 3Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio 4Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials 2
... The DexCom STS Continuous Glucose Monitoring System ... transmits blood glucose readings to the DexCom STS ... sensor which is inserted via the DexCom STS ... the skin where it is held in place ...
... Eclipse,Plus or 850 ECG medical ... capability. Doctors,maintain all the benefits ... and gain the,ability to view ... personal computers., With diagnostic-quality viewing ...
... For practices performing routine ... with QuickStep Wizard provides a,practical, ... tightly managed health care,environment. This ... available in a variety,of configurations ...
... that need an advanced ... Vision,Premier Holter System provides ... Vision Premier system,adds expanded ... comprehensive list of diagnostic,codes ...
Medicine Products: